Jun 19 |
Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
|
Jun 13 |
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)
|
Jun 12 |
Opthea announces placement, entitlement offer to raise up to $150M
|
Jun 12 |
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately A$227.3 million (US$150.0 million¹)
|
Jun 3 |
Opthea To Present at Clinical Trials at the Summit Meeting
|
May 28 |
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
|
May 1 |
Opthea Announces Upcoming Presentations at the Retina World Congress 2024
|
Apr 25 |
Opthea to Present at the OIS Retina Innovation Summit at ARVO
|
Apr 12 |
Owning 39% shares,institutional owners seem interested in Opthea Limited (ASX:OPT),
|
Apr 4 |
Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference
|